246 related articles for article (PubMed ID: 9658119)
21. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.
Driscoll MD; Golinelli MP; Hughes SH
J Virol; 2001 Jan; 75(2):672-86. PubMed ID: 11134281
[TBL] [Abstract][Full Text] [Related]
22. Steps of the acceptor invasion mechanism for HIV-1 minus strand strong stop transfer.
Chen Y; Balakrishnan M; Roques BP; Bambara RA
J Biol Chem; 2003 Oct; 278(40):38368-75. PubMed ID: 12878597
[TBL] [Abstract][Full Text] [Related]
23. Trans-activation of the 5' to 3' viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV1 RNA.
Darlix JL; Vincent A; Gabus C; de Rocquigny H; Roques B
C R Acad Sci III; 1993 Aug; 316(8):763-71. PubMed ID: 7519118
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site.
Li X; Quan Y; Arts EJ; Li Z; Preston BD; de Rocquigny H; Roques BP; Darlix JL; Kleiman L; Parniak MA; Wainberg MA
J Virol; 1996 Aug; 70(8):4996-5004. PubMed ID: 8764006
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence.
Bernacchi S; Stoylov S; Piémont E; Ficheux D; Roques BP; Darlix JL; Mély Y
J Mol Biol; 2002 Mar; 317(3):385-99. PubMed ID: 11922672
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.
Post K; Olson ED; Naufer MN; Gorelick RJ; Rouzina I; Williams MC; Musier-Forsyth K; Levin JG
Retrovirology; 2016 Dec; 13(1):89. PubMed ID: 28034301
[TBL] [Abstract][Full Text] [Related]
27. Fidelity of plus-strand priming requires the nucleic acid chaperone activity of HIV-1 nucleocapsid protein.
Post K; Kankia B; Gopalakrishnan S; Yang V; Cramer E; Saladores P; Gorelick RJ; Guo J; Musier-Forsyth K; Levin JG
Nucleic Acids Res; 2009 Apr; 37(6):1755-66. PubMed ID: 19158189
[TBL] [Abstract][Full Text] [Related]
28. During the early phase of HIV-1 DNA synthesis, nucleocapsid protein directs hybridization of the TAR complementary sequences via the ends of their double-stranded stem.
Godet J; de Rocquigny H; Raja C; Glasser N; Ficheux D; Darlix JL; Mély Y
J Mol Biol; 2006 Mar; 356(5):1180-92. PubMed ID: 16406407
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus nucleocapsid protein stimulates strand transfer from internal regions of heteropolymeric RNA templates.
DeStefano JJ
Arch Virol; 1995; 140(10):1775-89. PubMed ID: 7503678
[TBL] [Abstract][Full Text] [Related]
30. Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis.
Beltz H; Clauss C; Piémont E; Ficheux D; Gorelick RJ; Roques B; Gabus C; Darlix JL; de Rocquigny H; Mély Y
J Mol Biol; 2005 May; 348(5):1113-26. PubMed ID: 15854648
[TBL] [Abstract][Full Text] [Related]
31. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein.
Gabus C; Auxilien S; Péchoux C; Dormont D; Swietnicki W; Morillas M; Surewicz W; Nandi P; Darlix JL
J Mol Biol; 2001 Apr; 307(4):1011-21. PubMed ID: 11286552
[TBL] [Abstract][Full Text] [Related]
32. Formation of stable and functional HIV-1 nucleoprotein complexes in vitro.
Tanchou V; Gabus C; Rogemond V; Darlix JL
J Mol Biol; 1995 Oct; 252(5):563-71. PubMed ID: 7563074
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of minus strand strong stop transfer in HIV-1 reverse transcription.
Chen Y; Balakrishnan M; Roques BP; Fay PJ; Bambara RA
J Biol Chem; 2003 Mar; 278(10):8006-17. PubMed ID: 12499370
[TBL] [Abstract][Full Text] [Related]
34. Structural Insights into the HIV-1 Minus-strand Strong-stop DNA.
Chen Y; Maskri O; Chaminade F; René B; Benkaroun J; Godet J; Mély Y; Mauffret O; Fossé P
J Biol Chem; 2016 Feb; 291(7):3468-82. PubMed ID: 26668324
[TBL] [Abstract][Full Text] [Related]
35. Role of the structure of the top half of HIV-1 cTAR DNA on the nucleic acid destabilizing activity of the nucleocapsid protein NCp7.
Beltz H; Piémont E; Schaub E; Ficheux D; Roques B; Darlix JL; Mély Y
J Mol Biol; 2004 May; 338(4):711-23. PubMed ID: 15099739
[TBL] [Abstract][Full Text] [Related]
36. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
[TBL] [Abstract][Full Text] [Related]
37. The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA(3Lys) genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1.
Huang Y; Khorchid A; Gabor J; Wang J; Li X; Darlix JL; Wainberg MA; Kleiman L
J Virol; 1998 May; 72(5):3907-15. PubMed ID: 9557676
[TBL] [Abstract][Full Text] [Related]
38. Template-primer binding affinity and RNase H cleavage specificity contribute to the strand transfer efficiency of HIV-1 reverse transcriptase.
Luczkowiak J; Matamoros T; Menéndez-Arias L
J Biol Chem; 2018 Aug; 293(35):13351-13363. PubMed ID: 29991591
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody-mediated inhibition of RNA binding and annealing activities of HIV type 1 nucleocapsid protein.
Tanchou V; Delaunay T; De Rocquigny H; Bodeus M; Darlix JL; Roques B; Benarous R
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):983-93. PubMed ID: 7529035
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein.
Vo MN; Barany G; Rouzina I; Musier-Forsyth K
J Mol Biol; 2006 Oct; 363(1):244-61. PubMed ID: 16962137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
